BBLG logo

Bone Biologics (BBLG) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

13 October 2021

Indexes:

Not included

Description:

Bone Biologics (BBLG) focuses on developing innovative treatments for bone healing and regeneration. Their advanced technologies aim to improve recovery from fractures and orthopedic surgeries, enhancing patient outcomes through effective biological solutions. BBLG is dedicated to advancing bone health and supporting medical professionals in their practices.

Events Calendar

Earnings

Next earnings date:

May 14, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Dec 20, 2023

Analyst ratings

Recent major analysts updates

13 Apr '23 EF Hutton
Buy
03 Apr '23 EF Hutton
Buy
18 Oct '22 EF Hutton
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Why Is Bone Biologics (BBLG) Stock Down 38% Today?
Why Is Bone Biologics (BBLG) Stock Down 38% Today?
Why Is Bone Biologics (BBLG) Stock Down 38% Today?
BBLG
InvestorPlace17 November 2023

Bone Biologics (NASDAQ: BBLG ) stock is falling on Friday after the medical device company's shares underwent a major rally the day prior. That rally was caused by heavy trading of BBLG stock.

Why Is Bone Biologics (BBLG) Stock Up 84% Today?
Why Is Bone Biologics (BBLG) Stock Up 84% Today?
Why Is Bone Biologics (BBLG) Stock Up 84% Today?
BBLG
InvestorPlace16 November 2023

Bone Biologics (NASDAQ: BBLG ) stock is rocketing higher despite a lack of news from the medical device company on Thursday. There are no new press releases or filings with the Securities and Exchange Commission that explain why BBLG stock is up today.

Penny Stocks to Watch: Why Is ELOX Stock Skyrocketing?
Penny Stocks to Watch: Why Is ELOX Stock Skyrocketing?
Penny Stocks to Watch: Why Is ELOX Stock Skyrocketing?
BBLG
PennyStocks11 July 2023

Most traders dream of hitting it big, and penny stocks are some of the most attractive for day traders. It can be any given session where we see at least a handful of cheap stocks under $5 explode.

Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month - Bone Biologics (NASDAQ:BBLG), Fresh2 Group (NASDAQ:FRES)
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month - Bone Biologics (NASDAQ:BBLG), Fresh2 Group (NASDAQ:FRES)
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month - Bone Biologics (NASDAQ:BBLG), Fresh2 Group (NASDAQ:FRES)
BBLG
Benzinga21 June 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Bone Biologics stock plummets more than 50% after stock offering prices at deep discount
Bone Biologics stock plummets more than 50% after stock offering prices at deep discount
Bone Biologics stock plummets more than 50% after stock offering prices at deep discount
BBLG
Market Watch15 June 2023

Shares of Bone Biologics Corp. BBLG plummeted 51.9% toward a record low in premarket trading Thursday, after the developer of regenerative medicine for bones announced the pricing of its relatively large stock offering at a deep discount. The company raised $5 million, as it said overnight that it sold 2.54 million shares, which represented 15.2% of the shares outstanding, at price of $1.97 per share.

Why Is Bone Biologics (BBLG) Stock Down 52% Today?
Why Is Bone Biologics (BBLG) Stock Down 52% Today?
Why Is Bone Biologics (BBLG) Stock Down 52% Today?
BBLG
InvestorPlace15 June 2023

Bone Biologics (NASDAQ: BBLG ) stock is breaking down on Thursday after the company announced the details of a public share offering. Bone Biologics has revealed its public offering prices shares of BBLG stock at $1.97 each.

FAQ

  • What is the primary business of Bone Biologics?
  • What is the ticker symbol for Bone Biologics?
  • Does Bone Biologics pay dividends?
  • What sector is Bone Biologics in?
  • What industry is Bone Biologics in?
  • What country is Bone Biologics based in?
  • When did Bone Biologics go public?
  • Is Bone Biologics in the S&P 500?
  • Is Bone Biologics in the NASDAQ 100?
  • Is Bone Biologics in the Dow Jones?
  • When was Bone Biologics's last earnings report?
  • When does Bone Biologics report earnings?
  • Should I buy Bone Biologics stock now?

What is the primary business of Bone Biologics?

Bone Biologics (BBLG) focuses on developing innovative treatments for bone healing and regeneration. Their advanced technologies aim to improve recovery from fractures and orthopedic surgeries, enhancing patient outcomes through effective biological solutions. BBLG is dedicated to advancing bone health and supporting medical professionals in their practices.

What is the ticker symbol for Bone Biologics?

The ticker symbol for Bone Biologics is NASDAQ:BBLG

Does Bone Biologics pay dividends?

No, Bone Biologics does not pay dividends

What sector is Bone Biologics in?

Bone Biologics is in the Healthcare sector

What industry is Bone Biologics in?

Bone Biologics is in the Medical Devices industry

What country is Bone Biologics based in?

Bone Biologics is headquartered in United States

When did Bone Biologics go public?

Bone Biologics's initial public offering (IPO) was on 13 October 2021

Is Bone Biologics in the S&P 500?

No, Bone Biologics is not included in the S&P 500 index

Is Bone Biologics in the NASDAQ 100?

No, Bone Biologics is not included in the NASDAQ 100 index

Is Bone Biologics in the Dow Jones?

No, Bone Biologics is not included in the Dow Jones index

When was Bone Biologics's last earnings report?

Bone Biologics's most recent earnings report was on 14 November 2024

When does Bone Biologics report earnings?

The next expected earnings date for Bone Biologics is 14 May 2025

Should I buy Bone Biologics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions